New behavioral program aims to keep people with mental illness out of jail

NCT ID NCT06290648

First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This study tests a new group program called Forging New Paths for adults with serious mental illness who have also been involved with the criminal justice system. The program combines cognitive behavioral therapy with social learning techniques to reduce aggression and help people stay in the community. About 72 participants will be randomly assigned to receive the program plus usual care, or usual care alone, and researchers will track changes in aggression, criminal attitudes, and community stability over several months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Forging New Paths (a group behavioral intervention combining cognitive behavioral therapy and social learning principles)
What this could lead to
If it works, this could provide a new, practical tool for mental health clinics to help people with mental illness avoid further legal trouble and stay safely in their communities.
What could go wrong
This is a small, early-stage study with only 72 participants, so results may not apply broadly. The intervention is new and unproven, and it may not reduce aggression or improve community tenure as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, 27599, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.